Clinical Trials in Nashville

Showing 15021-15040 of 20,298 trials

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

NCT01635712

Hsp90 is a chemical in the body that is involved int he promotion of cancer. SNX-5422 is an experimental drug that blocks Hsp90.

Cancer

Esanex Inc.10 participantsStarted Feb 2014

Sacramento, California, United States • Augusta, Georgia, United States • Hackensack, New Jersey, United States +2 more locations

COMPLETED< 1 mile

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

NCT01590615

This registry will remain open for approximately 5 years (4 years of enrollment + 1 year of follow up). Subjects will be followed until Orthotopic Liver Transplant (OLT), resolution of liver decompensation, death, or conclusion of the registry.

Hepatitis B

Gilead Sciences54 participantsStarted Apr 2012

Los Angeles, California, United States • Los Angeles, California, United States • Palo Alto, California, United States +24 more locations

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

Find Trials by Condition in Nashville

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Inhibitor Development in Patients With Hemophilia A Undergoing Surgery

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

Gamma Vacuum Foil (GVF) Versus Cross-linked Polyethylene in Total Knee Arthroplasty Study

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy